Oscar Health Q4 2023 GAAP EPS $(0.66) Beats $(0.73) Estimate, Sales $1.43B Beat $1.42B Estimate
Portfolio Pulse from Benzinga Newsdesk
Oscar Health (OSCR) reported Q4 2023 earnings with a GAAP EPS of $(0.66), surpassing the $(0.73) estimate. Sales reached $1.43B, exceeding the $1.42B estimate, marking a 43.90% increase from the previous year.
February 07, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oscar Health reported a better-than-expected Q4 2023 with a GAAP EPS of $(0.66) and sales of $1.43B, indicating strong performance and growth.
Oscar Health's Q4 2023 performance exceeded analyst expectations in both earnings per share and sales, indicating a positive trend in the company's financial health and operational efficiency. The significant year-over-year sales growth further emphasizes the company's expanding market presence and operational success, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100